Drawing for CANTX

USPTO serial 79176026

CANTX

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
Examiner
SABLE, ERIC
Law office
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CANTX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005House mark for pharmaceutical preparations for the treatment of cancer, excluding use as a product mark for pharmaceuticals for colon cancer or cancer of the gastrointestinal systemSECTION 70 - CANCELLED
042Scientific research services; research and development of new products; advisory services relating to scientific research; biotechnology research; medical research; chemical researchSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026DETHDEATH OF INTERNATIONAL REGISTRATION
Dec 11, 2025DETHDEATH OF INTERNATIONAL REGISTRATION
Aug 14, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Jul 8, 2017FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 19, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 17, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 28, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 12, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 12, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 17, 2016MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 17, 2016ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 11, 2015RFNTREFUSAL PROCESSED BY IB
Nov 21, 2015MAFRAPPLICATION FILING RECEIPT MAILED
Nov 20, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 20, 2015RFRRREFUSAL PROCESSED BY MPU
Nov 19, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 18, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2015DOCKASSIGNED TO EXAMINER
Nov 17, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 15, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance